Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2018 Filed Sep 27, 2018 17:48 UTC |
ALBINI EDWARD CCFO and Secretary
|
GrantStock Option (right to buy Common Stock) · Derivative | 129,132 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052476 · doc4.xml · derivative · entry 1 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,132 Underlying: Common Stock · 129,132 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:51 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052480 · doc4.xml · derivative · entry 2 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock · 22,727 shares Expires 2021-09-25 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:51 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 136,363 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052480 · doc4.xml · derivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,363 Underlying: Common Stock · 136,363 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:56 UTC |
JANNEY DANIELDirector · 10% owner
|
GrantStock Option (right to buy Common Stock) · Derivative | 26,033 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052483 · doc4.xml · derivative · entry 1 JANNEY DANIEL · CIK 0001198325 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,033 Underlying: Common Stock · 26,033 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 18:06 UTC |
Ross Michael JayDirector · 10% owner
|
GrantStock Option (right to buy Common Stock) · Derivative | 26,033 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052495 · doc4.xml · derivative · entry 1 Ross Michael Jay · CIK 0001254452 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,033 Underlying: Common Stock · 26,033 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 18:03 UTC |
NEWELL WILLIAM JDirector · CEO & President
|
GrantRestricted Stock Unit (RSU) · Derivative | 75,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052492 · doc4.xml · derivative · entry 2 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,757 Underlying: Common Stock · 75,757 shares Expires 2021-09-25 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 18:03 UTC |
NEWELL WILLIAM JDirector · CEO & President
|
GrantStock Option (right to buy Common Stock) · Derivative | 454,545 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052492 · doc4.xml · derivative · entry 1 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,545 Underlying: Common Stock · 454,545 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:55 UTC |
Hallam TrevorChief Science Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 13,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052482 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,774 Underlying: Common Stock · 13,774 shares Expires 2020-09-25 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/2 of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:55 UTC |
Hallam TrevorChief Science Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 33,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052482 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,057 Underlying: Common Stock · 33,057 shares Expires 2021-09-25 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 17:55 UTC |
Hallam TrevorChief Science Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 198,347 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052482 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,347 Underlying: Common Stock · 198,347 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 22:03 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 25,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052491 · doc4.xml · derivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,826 Underlying: Common Stock · 25,826 shares Expires 2021-09-25 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 22:03 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 154,958 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052491 · doc4.xml · derivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,958 Underlying: Common Stock · 154,958 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 21:50 UTC |
Dybbs MichaelDirector
|
GrantStock Option (right to buy Common Stock) · Derivative | 26,033 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052479 · doc4.xml · derivative · entry 1 Dybbs Michael · CIK 0001601264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,033 Underlying: Common Stock · 26,033 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 22:01 UTC |
Lobacki Joseph MDirector
|
GrantStock Option (right to buy Common Stock) · Derivative | 26,033 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052490 · doc4.xml · derivative · entry 1 Lobacki Joseph M · CIK 0001536193 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,033 Underlying: Common Stock · 26,033 shares Expires 2028-09-25 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.